
Recent approval of photobiomodulation (PBM) applications acknowledges clinical benefits across various areas, including tissue repair and cognitive enhancement, despite a lack of standardized treatment protocols. The findings suggest promising outcomes in microcirculation and neuropathic recovery, but stakeholders are advised to remain cautious due to the need for higher-quality, large-scale studies to confirm the efficacy of these therapies. As the risk of misinformation remains low, the healthcare community is urged to frame PBM's applications with appropriate caution until more robust evidence is available.

Title not available for this citation.
“The SER + PBM treatment was particularly effective, showing the greatest proportion of type I collagen and statistical superiority over the other interventions.”

Title not available for this citation.
“Transcranial PBM causes a significant increase in vertical and horizontal vergence indices, which indicates an improvement in eye movement conjugation in healthy volunteers.”

Title not available for this citation.
“Vertical and horizontal VRx after tPBM were significantly higher than before the procedure: 0.878 [0.843; 0.902] vs. 0.783 [0.702; 0.829], p < 0.001, respectively and 0.875 [0.834; 0.912] vs. 0.927 [0.921; 0.93], p < 0.001, respectively.”